HomeCompareLACQU vs MRK

LACQU vs MRK: Dividend Comparison 2026

LACQU yields 14.49% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LACQU wins by $21.0K in total portfolio value
10 years
LACQU
LACQU
● Live price
14.49%
Share price
$13.80
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.8K
Annual income
$3,552.86
Full LACQU calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — LACQU vs MRK

📍 LACQU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLACQUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LACQU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LACQU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LACQU
Annual income on $10K today (after 15% tax)
$1,231.88/yr
After 10yr DRIP, annual income (after tax)
$3,019.93/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, LACQU beats the other by $2,212.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LACQU + MRK for your $10,000?

LACQU: 50%MRK: 50%
100% MRK50/50100% LACQU
Portfolio after 10yr
$41.3K
Annual income
$2,251.58/yr
Blended yield
5.46%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LACQU
No analyst data
Altman Z
-25.8
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LACQU buys
0
MRK buys
0
No recent congressional trades found for LACQU or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLACQUMRK
Forward yield14.49%3.25%
Annual dividend / share$2.00$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$51.8K$30.7K
Annual income after 10y$3,552.86$950.29
Total dividends collected$24.5K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LACQU vs MRK ($10,000, DRIP)

YearLACQU PortfolioLACQU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,149$1,449.28$11,192$351.54+$957.00LACQU
2$14,645$1,645.57$12,524$392.70+$2.1KLACQU
3$17,524$1,853.88$14,015$438.65+$3.5KLACQU
4$20,824$2,073.20$15,682$489.96+$5.1KLACQU
5$24,584$2,302.42$17,547$547.23+$7.0KLACQU
6$28,846$2,540.34$19,632$611.16+$9.2KLACQU
7$33,650$2,785.66$21,963$682.53+$11.7KLACQU
8$39,043$3,037.08$24,571$762.18+$14.5KLACQU
9$45,069$3,293.25$27,486$851.08+$17.6KLACQU
10$51,777$3,552.86$30,745$950.29+$21.0KLACQU

LACQU vs MRK: Complete Analysis 2026

LACQUStock

Leisure Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination. The company was founded in 2017 and is based in New York, New York.

Full LACQU Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this LACQU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LACQU vs SCHDLACQU vs JEPILACQU vs OLACQU vs KOLACQU vs MAINLACQU vs JNJLACQU vs ABBVLACQU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.